Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2012 | CITED2 functions as a molecular switch of cytokine-induced proliferation and quiescence | Chou, Y. -T.; Hsieh, C. -H.; Chiou, S. -H.; Hsu, C. -F.; Kao, Y. -R.; Lee, C. -C.; Chung, C. -H.; Wang, Y. -H.; Hsu, H. -S.; Pang, S. -T.; Shieh, Y. -S.; Wu, C. -W. | Cell Death and Differentiation doi: 10.1038/cdd.2012.91 | | | |
2010 | Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. | Chiou, S. -H.; Wang, M. -L.; Chou, Y. -T.; Chen, C. -J.; Hong, C. -F.; Hsieh, W. -J.; Chang, H. -T.; Chen, Y. -S.; Lin, T. -W.; Hsu, H. -S.; Wu, C. -W. | CANCER RESEARCH THERAPY & CONTROL 70(24):10433-44 | | | |
2010 | EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF | Chou, Y. -T.; Lin, H. -H.; Lien, Y. -C.; Wang, Y. -H.; Hong, C. -F.; Kao, Y. -R.; Lin, S. -C.; Chang, Y. -C.; Lin, S. -Y. ; Chen, H. -J.; Yeh, S. -D.; Wu, C. -W. | Cancer research 70(21), 8822-8831 | | | |
- | PML is a Negative Regulator of Nuclear EGFR’s Transcriptional Activity in Lung Cancer | Kuo, H. -Y.; Chen, Y. -C.; Chang, H. -Y.; Lin, E. -H.; Jeng, J. -C.; Chou, Y. -T.; Wang, M. -L.; Shih, H. -M.; Wu, C. -W. | Cancer Research | | | |
- | SOX2-mediated oncogenic stem cell signaling in lung cancer | Chou, Y. -T.; Lee, C. -C.; Hsiao, S. -H.; Lin, S. -E.; Lin, S. -C.; Chung, C. -H.; Chung, C. -H.; Kao, Y. -R.; Wang, Y. -H.; Chen, C. -T.; Wei, Y. -H.; Wu, C. -W. | EMBO Molecular Medicine | | | |